Umbilical Cord Mesenchymal Stem Cells Clinical Trials

2 actively recruiting trials

Also known as: UC-MSCs

Pipeline

Phase 1/2: 1

Top Sponsors

PT. Prodia Stem Cell Indonesia1
General Hospital of Shenyang Military Region1

Indications

Liver Disease1
Diabetic Nephropathy Type 21
End Stage Liver Disease1
Diabetes1

Other2 trials

Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients with ESLD

N/A

Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.